Immune Profiling of SARS-CoV-2; What We Know and What We Don't Know

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Coronavirus disease 2019 (COVID-19) presents a significant global health challenge with complex pathogenesis and no definitive cure.
• Understanding the immune response is critical for managing COVID-19, driving ongoing research into various aspects of immunity.
• Immune cell alterations are observed in COVID-19 patients, but comprehensive comparisons across clinical spectrums are needed.

Purpose of the Study:

• To review recent investigations on immune cells in patients diagnosed with COVID-19.
• To analyze and discuss the distinct immune profiles associated with different clinical presentations of COVID-19.
• To compare immune cell differences between healthy individuals and patients with asymptomatic, mild, moderate, and severe COVID-19.

Main Methods:

• Systematic review of recent scientific literature focusing on immune cell analysis in COVID-19.
• Comparative analysis of immune cell data from patients with varying COVID-19 severity.
• Examination of immunological markers and cell populations in relation to clinical outcomes.

Main Results:

• Significant alterations in immune cell populations (e.g., lymphocytes, neutrophils) are evident in COVID-19 patients.
• Distinct immune profiles correlate with disease severity, showing marked differences between asymptomatic and severe cases.
• Specific immune cell dysregulations are associated with the pathogenesis and progression of COVID-19.

Conclusions:

• Immune cell profiling is crucial for understanding COVID-19 pathogenesis and clinical variability.
• The findings highlight potential biomarkers for predicting disease severity and guiding therapeutic strategies.
• Further research into immune responses can inform the development of effective treatments and vaccines for COVID-19.